In a new study, the OMRF compound OKN-007 is being combined with the current standard-of-care medication for glioblastoma.
Glioblastoma is an aggressive form of brain cancer with no cure, but a new OMRF discovery offers hope.
As Mike Schuster nears the three-year anniversary of his diagnosis with glioblastoma, he’s already doubled the life expectancy for patients with the deadly cancer.
Agreement will expand clinical trials of glioblastoma drug
Technology Ventures works to pair scientists with industry partners.
OMRF’s biomarker discoveries could bring new therapies for beating gliomas.